EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte Studie

Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours

Shenqiang Yan iD, Ying Zhou, Maarten G Lansberg, David S Liebeskind, Changzheng Yuan, Han Yu, Fujian Chen, Hongfang Chen, Bing Zhang, Lingqun Mao, Xiaoling Zhang, Xiaona Wang und 12 weitere

New England Journal of Medicine · 03.04.2025 · 392 (13) · 1288-1296

DOI: 10.1056/nejmoa2413344 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 03.04.2025. Verfasst von Shenqiang Yan und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Fibrinolytic Agents, Ischemic Stroke, Thrombolytic Therapy, Tissue Plasminogen Activator. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibrinolytic AgentsIschemic StrokeThrombolytic TherapyTissue Plasminogen ActivatorAgedFemaleHumansMaleMiddle AgedIntracranial HemorrhagesTime FactorsTime-to-TreatmentInfusions, IntravenousIntention to Treat AnalysisDisability EvaluationTreatment Outcome

Substanzen

Fibrinolytic AgentsTissue Plasminogen Activator

Autor:innen und Institutionen

  • Department of Neurology, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
  • Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA.
  • Department of Neurology, University of California, Los Angeles, Los Angeles.
  • School of Public Health, Zhejiang University, Hangzhou, China.
  • Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston.
  • Department of Neurology, Yongjia People's Hospital, Wenzhou, China.

ORCID-Profile: Shenqiang Yan, Hui Chen, Bruce C V Campbell

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yan, S., Zhou, Y., Lansberg, M. G., Liebeskind, D. S., Yuan, C., Yu, H., Chen, F., Chen, H., Zhang, B., Mao, L., Zhang, X., Wang, X., Zhang, X., Chen, Y., Zhou, H., Zhong, W., He, Y., Chen, K., Wang, J., …, & EXPECTS Group (2025). Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours. New England Journal of Medicine, 392(13), 1288-1296. https://doi.org/10.1056/nejmoa2413344

Vancouver

Yan S, Zhou Y, Lansberg MG, Liebeskind DS, Yuan C, Yu H, et al. Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours. New England Journal of Medicine. 2025;392(13):1288-1296. doi:10.1056/nejmoa2413344

BibTeX
@article{Yan2025,
  author = {Yan, Shenqiang and Zhou, Ying and Lansberg, Maarten G and Liebeskind, David S and Yuan, Changzheng and Yu, Han and Chen, Fujian and Chen, Hongfang and Zhang, Bing and Mao, Lingqun and Zhang, Xiaoling and Wang, Xiaona and Zhang, Xuting and Chen, Yi and Zhou, Huan and Zhong, Wansi and He, Yaode and Chen, Kun and Wang, Jianbing and Chen, Hui and Huang, Yuhui and Campbell, Bruce C V and Lou, Min and EXPECTS Group, EXPECTS Group},
  title = {Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {13},
  pages = {1288--1296},
  doi = {10.1056/nejmoa2413344}
}
Kostenlos starten →